Lipid peroxidation is not the underlying cause of renal injury in hyperoxaluric rats

Kidney International

Volumn 68, Issue 6, 2005, Pages 2629-2638

  Green, Mike L ^a   Freel, Robert W ^a   Hatch, Marguerite ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Antioxidant; Calcium oxalate; Chronic renal failure; Free radicals; Kidney stone; Reactive oxygen species; Urolithiasis

Indexed keywords

8 ISOPROSTANE; ALKALINE PHOSPHATASE; BETA N ACETYLGALACTOSAMINIDASE; BIOLOGICAL MARKER; CATALASE; ETHYLENE GLYCOL; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; KIDNEY ENZYME; LACTATE DEHYDROGENASE; LIPID HYDROPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE MARKER; ENZYME ASSAY; ENZYMURIA; HYPEROXALURIA; KIDNEY CORTEX; KIDNEY INJURY; KIDNEY TUBULE DISORDER; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; TISSUE LEVEL; UNINEPHRECTOMY; URINALYSIS; URINARY EXCRETION;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CALCIUM OXALATE; HYPEROXALURIA; KIDNEY; KIDNEY FAILURE, CHRONIC; LIPID PEROXIDATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; URINARY CALCULI;

EID: 32844474705     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00735.x     Document Type: Article

References (50)

1. CURHAN GC, WILLETT WC, SPEIZER FE, et al: Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 59:2290-2298, 2001
2. McCoNNELL N, CAMPBELL S, GILLANDERS I, et al: Risk factors for developing renal stones in inflammatory bowel disease. BJU Int 89:835-841, 2002
3. KHAN SR: Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron Exp Nephrol 98:e55-e60, 2004
4. KHAN SR: Crystal-induced inflammation of the kidneys: Results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 8:75-88, 2004
5. MUTHUKUMAR A, SELVAM R: Renal injury mediated calcium oxalate nephrolithiasis: Role of lipid peroxidation. Ren Fail 19:401-408, 1997
6. JONASSEN JA, CAO LC, HONEYMAN T, et al: Intracellular events in the initiation of calcium oxalate stones. Nephron Exp Nephrol 98:e61-e64, 2004
7. HACKETT RL, SHEVOCK PN, KHAN SR: Cell injury associated calcium oxalate crystalluria. J Urol 144:1535-1538, 1990
8. SELVAM R: Calcium oxalate stone disease: Role of lipid peroxidation and antioxidants. Urol Res 30:35-47, 2002
9. SCHEID C, KOUL H, HILL WA, et al: Oxalate toxicity in LLC-PK1 cells: Role of free radicals. Kidney Int 49:413-419, 1996
10. THAMILSELVAN S, HACKETT RL, KHAN SR: Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157:1059-1063, 1997
11. HUANG HS, MA MC, CHEN J, et al: Changes in renal hemodynamics and urodynamics in rats with chronic hyperoxaluria and after acute oxalate infusion: Role of free radicals. Neurourol Urodyn 22:176-182, 2003
12. HUANG HS, CHEN CF, CHIEN CT, et al: Possible biphasic changes of free radicals in ethylene glycol-induced nephrolithiasis in rats. BJU Int 85:1143-1149, 2000
13. HUANG HS, MA MC, CHEN J, et al: Changes in the oxidant-antioxidant balance in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Urol 167:2584-2593, 2002
14. THAMILSELVAN S, KHAN SR, MENON M: Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: Effect of antioxidants. Urol Res 31:3-9, 2003
15. RASHED T, MENON M, THAMILSELVAN S: Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: Effect of antioxidants. Am J Nephrol 24:557-568, 2004
16. HUANG HS, MA MC, CHEN CF, et al: Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 62:1123-1128, 2003
17. JONASSEN JA, COONEY R, KENNINGTON L, et al: Oxalate-induced changes in the viability and growth of human renal epithelial cells. J Am Soc Nephrol 10 (Suppl 14):S446-S451, 1999
18. HALLIWELL B, WHITEMAN M: Measuring reactive species and oxidative damage in vivo and in cell culture: How should you do it and what do the results mean? Br J Pharmacol 142:231-255, 2004
19. GUTTERIDGE JM, HALLIWELL B: Free radicals and antioxidants in the year 2000. A historical look to the future. Ann NY Acad Sci 899:136-147, 2000
20. JANERO DR: Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9:515-540, 1990
21. HALLIWELL B, GUTTERIDGE JM: Free Radicals in Biology and Medicine, 3rd ed., New York, Oxford University Press Inc., 1999
22. HATCH M, FREEL RW: Renal and intestinal handling of oxalate following oxalate loading in rats. Am J Nephrol 23:18-26, 2003
23. HATCH M, FREEL RW: Angiotensin II involvement in adaptive enteric oxalate excretion in rats with chronic renal failure induced by hyperoxaluria. Urol Res 31:426-432, 2003
24. SLOT C: Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 17:381-387, 1965
25. HEINEGARD D, TIDERSTROM G: Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta 43:305-310, 1973
26. MIHALJEVIC B, KATUSIN-RAZEM B, RAZEM D: The reevaluation of the ferric thiocyanate assay for lipid hydroperoxides with special considerations of the mechanistic aspects of the response. Free Radic Biol Med 21:53-63, 1996
27. JUNG K, HENKE W: Developmental changes of antioxidant enzymes in kidney and liver from rats. Free Radic Biol Med 20:613-617, 1996
28. STEEL RG, TORRIE JH: Principles and Procedures of Statistics. 2nd ed., New York, McGraw-Hill Book Company, 1980
29. SAS User's Guide: Basics, Version 5 ed., Carey, NC, SAS Institute Inc., 1985
30. HATCH M, FREEL RW, VAZIRI ND: Intestinal excretion of oxalate in chronic renal failure. J Am Soc Nephrol 5:1339-1343, 1994
31. GREEN ML, HATCH M, FREEL RW: Ethylene glycol induces hyperoxaluria without metabolic acidosis in rats. Am J Physiol Renal Physiol 289:F536-543, 2005
32. KHAN SR, SHEVOCK PN, HACKETT RL: Urinary enzymes and calcium oxalate urolithiasis. J Urol 142:846-849, 1989
33. PRICE RG: The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 38 (Suppl 1):S14-S19, 1992
34. PRICE RG: Urinary enzymes, nephrotoxicity and renal disease. Toxicology 23:99-134, 1982
35. OBERLEY TD, FRIEDMAN AL, MOSER R, et al: Effects of lead administration on developing rat kidney. II. Functional, morphologic, and immunohistochemical studies. Toxicol Appl Pharmacol 131:94-107, 1995
36. THAMILSELVAN S, BYER KJ, HACKETT RL, et al: Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J Urol 164:224-229, 2000
37. CAO LC, HONEYMAN TW, COONEY R, et al: Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int 66:1890-1900, 2004
38. KHAND FD, GORDGE MP, ROBERTSON WG, et al: Mitochondrial superoxide production during oxalate-mediated oxidative stress in renal epithelial cells. Free Radic Biol Med 32:1339-1350, 2002
39. 2 in the cytotoxic effects of oxalate in cultured renal epithelial cells. Kidney Int 56:1432-1441, 1999
40. SCHEID C, KOUL H, HILL WA, et al: Oxalate toxicity in LLC-PK1 cells, a line of renal epithelial cells. J Urol 155:1112-1116, 1996
41. MARONI PD, KOUL S, MEACHAM RB, et al: Effects of oxalate on IMCD cells: A line of mouse inner medullary collecting duct cells. Ann NY Acad Sci 1030:144-149, 2004
42. McMARTIN KE, WALLACE KB: Calcium oxalate monohydrate, a metabolite of ethylene glycol, is toxic for rat renal mitochondrial function. Toxicol Sci 84:195-200, 2005
43. BHANDARI A, KOUL S, SEKHON A, et al: Effects of oxalate on HK-2 cells, a line of proximal tubular epithelial cells from normal human kidney. J Urol 168:253-259, 2002
44. POLDELSKI V, JOHNSON A, WRIGHT S, et al: Ethylene glycol-mediated tubular injury: Identification of critical metabolites and injury pathways. Am J Kidney Dis 38:339-348, 2001
45. ROBERTS LJ, MORROW JD: Products of the isoprostane pathway: Unique bioactive compounds and markers of lipid peroxidation. Cell Mol Life Sci 59:808-820, 2002
46. ROBERTS LJ, MORROW JD: Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28:505-513, 2000
47. MAKINO A, SKELTON MM, Zou AP, et al: Increased renal medullary oxidative stress produces hypertension. Hypertension 39:667-672, 2002
48. CEDERBERG J, BASU S, ERIKSSON UJ: Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy. Diabetologia 44:766-774, 2001
49. CRUZAN G, CORLEY RA, HARD GC, et al: Subchronic toxicity of ethylene glycol in Wistar and F-344 rats related to metabolism and clearance of metabolites. Toxicol Sci 81:502-511, 2004
50. CHABRASHVILI T, KITTYAKARA C, BLAU J, et al: Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 285:R117-R124, 2003